Ahmed Alamer

19PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Cardiology (incl. cardiovascular diseases)Clinical pharmacy and pharmacy practicePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 02, 2026
Cost-effectiveness of pembrolizumab plus chemoradiotherapy versus placebo plus chemoradiotherapy for high-risk locally advanced cervical cancer in Saudi Arabia: A model-based economic evaluation.

|Jul 01, 2026
Treatment trajectories and patterns following non-medical switching to biosimilar adalimumab in patients with hidradenitis suppurativa: a retrospective observational multicenter study from Saudi Arabia.

|May 04, 2026
Phenotype-Specific Mortality Outcomes with Dipeptidyl Peptidase-4 Inhibitors in Heart Failure and Diabetes: Real-World Evidence from a Retrospective Single-Center Cohort Study.

|Aug 19, 2024
Short term effectiveness of ustekinumab versus vedolizumab in Crohn's disease after failure of anti-TNF agents: An observational comparative study design with a Bayesian analysis.

Ahmad Alamer, Lina H Al Lehaibi, Mukhtar Alomar

|Jul 26, 2024
Insight into Current Practices of Community Pharmacists in Topical Corticosteroid Prescribing and Counseling: Cross-Sectional Survey Study from Saudi Arabia.

Sawsan M Kurdi, Ahmad Alamer, Arjwan Alqarni

|May 25, 2024
Evaluation of Serial Procalcitonin Levels for the Optimization of Antibiotic Use in Non-Critically Ill COVID-19 Patients.

Abdulaziz S Almulhim, Mohammed A Alabdulwahed, Fatimah F Aldoughan

Pageof 4

Frequent Collaborators

5 joint publications

Abdulaziz S Almulhim

4 joint publications

Ivo Abraham

2 joint publications

Ziyad S Almalki

2 joint publications

Fawaz M Alotaibi